Prognostic value of post-transplantation Wilms' tumor gene 1 expression in acute myeloid leukaemia subgroup according to different pre-transplant disease status.

The article reports that acute myeloid leukaemia is a heterogeneous disease that has been explored in depth using cytogenetic and molecular techniques. Topics include examines allogeneic haematopoietic stem cell transplantation is a curative therapy for AML and considered relapse remains an important problem as extensive evidence has shown that Wilms' tumor gene 1 expression is a useful biomarker for measurable/minimal residual disease monitoring in AML.